Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus

BACKGROUND: Hepatitis C virus-positive (HCV+) kidney transplant (KT) recipients are at increased risks of rejection and graft failure. The optimal induction agent for this population remains controversial, particularly regarding concerns that anti-thymocyte globulin (ATG) might increase HCV-related...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation
Main Authors: Bae, Sunjae, Durand, Christine M., Garonzik-Wang, Jacqueline M., Chow, Eric K. H., Kucirka, Lauren M., McAdams-DeMarco, Mara A., Massie, Allan B., Al Ammary, Fawaz, Coresh, Josef, Segev, Dorry L.
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7534413/
https://ncbi.nlm.nih.gov/pubmed/32433232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000002959
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items